-+ 0.00%
-+ 0.00%
-+ 0.00%

ENANTA PHARMACEUTICALS - PHASE 2B TRIAL IN PEDIATRIC RSV PATIENTS TO START Q3 2026

Reuters·06/18/2026 11:00:00

Please log in to view news